The cost-effectiveness of physician assistants/associates: A systematic review of international evidence

被引:41
|
作者
van den Brink, G. T. W. J. [1 ,2 ]
Hooker, R. S. [3 ]
Van Vught, A. J. [2 ]
Vermeulen, H. [1 ,2 ]
Laurant, M. G. H. [1 ,2 ]
机构
[1] Radboud Univ Nijmegen Med Ctr, Radboud Inst Hlth Sci, IQ Healthcare, Nijmegen, Netherlands
[2] HAN Univ Appl Sci, Sch Hlth Studies, Nijmegen, Netherlands
[3] No Arizona Univ, Hlth Policy, Flagstaff, AZ 86011 USA
来源
PLOS ONE | 2021年 / 16卷 / 11期
关键词
CARE PROVIDER TYPE; NURSE-PRACTITIONERS; ASSISTANT MODEL; QUALITY; IMPACT; EFFICIENCY; MEDICINE; MANAGEMENT; OUTCOMES; METRICS;
D O I
10.1371/journal.pone.0259183
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background The global utilization of the physician assistant/associate (PA) is growing. Their increasing presence is in response to the rising demands of demographic changes, new developments in healthcare, and physician shortages. While PAs are present on four continents, the evidence of whether their employment contributes to more efficient healthcare has not been assessed in the aggregate. We undertook a systematic review of the literature on PA cost-effectiveness as compared to physicians. Cost-effectiveness was operationalized as quality, accessibility, and the cost of care. Methods and findings Literature to June 2021 was searched across five biomedical databases and filtered for eligibility. Publications that met the inclusion criteria were categorized by date, country, design, and results by three researchers independently. All studies were screened with the Risk of Bias in Non-randomised Studies-of Interventions (ROBIN-I) tool. The literature search produced 4,855 titles, and after applying criteria, 39 studies met inclusion (34 North America, 4 Europe, 1 Africa). Ten studies had a prospective design, and 29 were retrospective. Four studies were assessed as biased in results reporting. While most studies included a small number of PAs, five studies were national in origin and assessed the employment of a few hundred PAs and their care of thousands of patients. In 34 studies, the PA was employed as a substitute for traditional physician services, and in five studies, the PA was employed in a complementary role. The quality of care delivered by a PA was comparable to a physician's care in 15 studies, and in 18 studies, the quality of care exceeded that of a physician. In total, 29 studies showed that both labor and resource costs were lower when the PA delivered the care than when the physician delivered the care. Conclusions Most of the studies were of good methodological quality, and the results point in the same direction; PAs delivered the same or better care outcomes as physicians with the same or less cost of care. Sometimes this efficiency was due to their reduced labor cost and sometimes because they were more effective as producers of care and activity.
引用
收藏
页数:27
相关论文
共 50 条
  • [41] Enhanced recovery following hip and knee arthroplasty: a systematic review of cost-effectiveness evidence
    Pritchard, Mark G.
    Murphy, Jacqueline
    Cheng, Lok
    Janarthanan, Roshni
    Judge, Andrew
    Leal, Jose
    BMJ OPEN, 2020, 10 (01):
  • [42] Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases
    Zhu, Ye
    Swanson, Kristi M.
    Rojas, Ricardo L.
    Wang, Zhen
    St. Sauver, Jennifer L.
    Visscher, Sue L.
    Prokop, Larry J.
    Bielinski, Suzette J.
    Wang, Liewei
    Weinshilboum, Richard
    Borah, Bijan J.
    GENETICS IN MEDICINE, 2020, 22 (03) : 475 - 486
  • [43] Is There Evidence for Cognitive Intervention in Alzheimer Disease? A Systematic Review of Efficacy, Feasibility, and Cost-Effectiveness
    Alves, Jorge
    Magalhaes, Rosana
    Thomas, Roger E.
    Goncalves, Oscar F.
    Petrosyan, Agavni
    Sampaio, Adriana
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2013, 27 (03): : 195 - 203
  • [44] SYSTEMATIC REVIEW OF THE COST-EFFECTIVENESS OF MECHANICAL CIRCULATORY SUPPORT
    Nunes, A. J.
    Wiebe, N.
    Chatterley, P.
    MacArthur, R. G.
    Klarenbach, S. W.
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : S176 - S177
  • [45] COST-EFFECTIVENESS OF BORTIZOMIB FOR MULTIPLE MYELOMA: A SYSTEMATIC REVIEW
    Chen, W.
    Yang, Y.
    Du, F.
    Li, J.
    Chen, Y.
    VALUE IN HEALTH, 2015, 18 (07) : A456 - A456
  • [46] Digital health technologies: a systematic review of their cost-effectiveness
    Puleo, V.
    Gentili, A.
    Failla, G.
    Melnyk, A.
    Di Tanna, G.
    Ricciardi, W.
    Cascini, F.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31
  • [47] Systematic review of cost-effectiveness modelling studies for haemophilia
    Meier, Niklaus
    Ammann, Daniel
    Pletscher, Mark
    Probst, Jano
    Schwenkglenks, Matthias
    JOURNAL OF MEDICAL ECONOMICS, 2025, 28 (01) : 89 - 104
  • [48] COST-EFFECTIVENESS OF TARGETED PHARMACOTHERAPY - A SYSTEMATIC REVIEW OF THE LITERATURE
    Amler, N.
    Becker, T.
    Bierbaum, M.
    Schoeffski, O.
    VALUE IN HEALTH, 2014, 17 (07) : A407 - A407
  • [49] Telemedicine Cost-Effectiveness for Diabetes Management: A Systematic Review
    Lee, Jun Yang
    Lee, Shaun Wen Huey
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (07) : 492 - 500
  • [50] Cost-effectiveness of PARP inhibitors in malignancies: A systematic review
    Ding, Haiying
    He, Chaoneng
    Tong, Yinghui
    Fang, Qilu
    Mi, Xiufang
    Chen, Lingya
    Xin, Wenxiu
    Fang, Luo
    PLOS ONE, 2022, 17 (12):